153 related articles for article (PubMed ID: 8094550)
21. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
Eades SC; Moore JN
Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
[TBL] [Abstract][Full Text] [Related]
22. Human vasodilator responses to a dopamine agonist: possible mechanisms.
Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
[TBL] [Abstract][Full Text] [Related]
23. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
24. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Chen CJ; Apparsundaram S; Lokhandwala MF
J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
[TBL] [Abstract][Full Text] [Related]
25. The pharmacology of fenoldopam.
Nichols AJ; Ruffolo RR; Brooks DP
Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
[TBL] [Abstract][Full Text] [Related]
26. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
Montier F; Katchadourian P; Pratz J; Cavero I
J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
[TBL] [Abstract][Full Text] [Related]
28. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
Girbes AR; Smit AJ; Meijer S; Reitsma WD
Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with intravenous fenoldopam.
Holcslaw TL; Beck TR
Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
[TBL] [Abstract][Full Text] [Related]
31. Dopamine under alpha1-blockade, but not dopamine alone or fenoldopam, increases depressed gastric mucosal oxygenation.
Schwarte LA; Picker O; Schindler AW; Fournell A; Scheeren TW
Crit Care Med; 2004 Jan; 32(1):150-6. PubMed ID: 14707574
[TBL] [Abstract][Full Text] [Related]
32. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
Kohli JD; Glock D; Goldberg LI
J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
[TBL] [Abstract][Full Text] [Related]
33. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
[TBL] [Abstract][Full Text] [Related]
34. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
Ragsdale NV; Lynd M; Chevalier RL; Felder RA; Peach MJ; Carey RM
Hypertension; 1990 Jun; 15(6 Pt 2):914-21. PubMed ID: 1972140
[TBL] [Abstract][Full Text] [Related]
35. Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion.
Bass AS; Murphy MB
Clin Exp Hypertens A; 1991; 13(6-7):1127-51. PubMed ID: 1684742
[TBL] [Abstract][Full Text] [Related]
36. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
[TBL] [Abstract][Full Text] [Related]
37. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
[TBL] [Abstract][Full Text] [Related]
38. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
Kopia GA; Valocik RE
J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
[TBL] [Abstract][Full Text] [Related]
39. Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits.
Szabo B; Hedler L; Starke K
J Pharmacol Exp Ther; 1986 Dec; 239(3):881-6. PubMed ID: 2879034
[TBL] [Abstract][Full Text] [Related]
40. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
Gretler DD; Jones KC; Murphy MB
J Pharmacol Exp Ther; 1992 Feb; 260(2):491-8. PubMed ID: 1346635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
